Diuretics. Chemistry and Pharmacology. Joseph Weinstock. J. Med. Chem. , 1964, 7 (4), pp 576â576. DOI: 10.1021/jm00334a046. Publication Date: July 1964.
The Trifluoromethyl Group in Medical Chemistry. Harry L. Yale. J. Med. Chem. , 1958, 1 (2), pp 121â133. DOI: 10.1021/jm50003a001. Publication Date: April ...
Annual Review of Pharmacology. Alfred Burger. J. Med. Chem. , 1970, 13 (5), pp 1028â1028. DOI: 10.1021/jm00299a901. Publication Date: September 1970.
Drill's Pharmacology in Medicine. Chalmers L. Gemmill. J. Med. Chem. , 1966, 9 (6), pp 982â982. DOI: 10.1021/jm00324a061. Publication Date: November ...
Pharmacology. Principles and Practice. Joseph G. Cannon. Division of Medicinal and Natural Products Chemistry College of Pharmacy The University of Iowa
Jan 7, 2016 - *Phone: 0039-0532- 455921. ... on the design and synthesis of adenosine receptor ligands and antitumor compounds in collaboration with the company King Pharmaceuticals (North Carolina), now part of Pfizer. ... Citation data is made avai
Jan 7, 2016 - Moreover, CB2 receptor modulation promotes anti-inflammatory therapeutic responses in activated microglia, suggesting a regulatory role for CB2 ..... (213) A novel CB2 agonist has also been identified with high affinity versus CB2 recep
Jan 7, 2016 - He has presented more than 90 lectures as speaker in international congresses. He was founder with Prof. Pier Andrea Borea of the spin off Pharmeste involved in the discovery of TRPV1 compounds. Biography. Pier Andrea Borea received his
Jan 7, 2016 - Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists. Mojgan Aghazadeh Tabriziâ , Pier Giovanni Baraldiâ , Pier Andrea Boreaâ¡, and Katia Varaniâ¡. â Department of Chemical and
Dec 7, 2012 - Recognition of the Causative Agent of âPhossy Jawâ and âFragile Femurâ in Fumes Arising from White Phosphorus. William Banks Hinshaw ...
